XTL Biopharmaceuticals Ltd ADR

Yahoo Finance • 2 months ago

XTL Biopharmaceuticals announces 1-for-4 ADS ratio change

* XTL Biopharmaceuticals (XTLB [https://seekingalpha.com/symbol/XTLB]) will change its ADS ratio [https://seekingalpha.com/pr/20446334-xtl-biopharmaceuticals-announces-ads-ratio-change] from 1:100 to 1:400 effective March 25, 2026. * T... Full story

Yahoo Finance • 4 months ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from The Listing Qualifications Departmen... Full story

Yahoo Finance • 9 months ago

XTL Biopharmaceuticals shareholders approve board elections and private placement

XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) announced Monday that shareholders approved all proposals at the company’s Annual and Extraordinary General Meeting, held in Bnei Brak, Israel. The information is based on a statement released thro... Full story

Yahoo Finance • 9 months ago

XTL Biopharmaceuticals postpones shareholder meeting due to lack of quorum

XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, (TASE:XTLB).TA) announced Monday the postponement of its annual and extraordinary shareholders’ meeting, which had been scheduled for Monday, after legal quorum requirements were not met. The compa... Full story

Yahoo Finance • last year

XTL Names Mr. Noam Band as its New Chief Executive Officer

Brings a Wealth of Managerial Experience and Track Record RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”) announced today the appointment of Noam Ba... Full story

Yahoo Finance • 3 years ago

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel

Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating t... Full story

Yahoo Finance • 3 years ago

XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating t... Full story